When the AST/ALT ratio was <2.65, the incidence of adverse 90-day outcomes in patients with cirrhosis increased with an increase in the AST/ALT ratio; however, the acceleration of the increase was gradually attenuated (Figures 3D,b). Here, GPT is linked to Cirrhosis.